Disc Medicine annual free cash flow
2020
2021
2022
2023
2024
2025
Disc Medicine Free Cash Flow (FCF) History (IRON)
Disc Medicine reported −$181.3M in free cash flow for fiscal 2025, a decrease of $86.9M from the previous fiscal year.
View full Disc Medicine company overviewDisc Medicine free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$181.3M | −$86.9M | — | — |
| 2024 | 2024-12-31 | −$94.4M | −$20.9M | — | — |
| 2023 | 2023-12-31 | −$73.6M | −$31.1M | — | — |
| 2022 | 2022-12-31 | −$42.4M | −$14.8M | — | — |
| 2021 | 2021-12-31 | −$27.6M | $5.1M | — | — |
| 2020 | 2020-12-31 | −$32.7M | — | — | — |
Disc Medicine quarterly free cash flow
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$44.2M | $3.8M | — | — |
| Q1 2026 | 2026-03-31 | −$62.2M | −$20.0M | — | — |
| Q4 2025 | 2025-12-31 | −$43.3M | −$15.3M | — | — |
| Q3 2025 | 2025-09-30 | −$47.8M | −$30.5M | — | — |
| Q2 2025 | 2025-06-30 | −$48.0M | −$32.6M | — | — |
| Q1 2025 | 2025-03-31 | −$42.2M | −$8.6M | — | — |
| Q4 2024 | 2024-12-31 | −$28.0M | −$10.2M | — | — |
| Q3 2024 | 2024-09-30 | −$17.4M | −$9.8M | — | — |
| Q2 2024 | 2024-06-30 | −$15.4M | −$2.7M | — | — |
| Q1 2024 | 2024-03-31 | −$33.7M | $1.8M | — | — |
| Q4 2023 | 2023-12-31 | −$17.8M | −$8.1M | — | — |
| Q3 2023 | 2023-09-30 | −$7.5M | $2.2M | — | — |
| Q2 2023 | 2023-06-30 | −$12.7M | −$3.5M | — | — |
| Q1 2023 | 2023-03-31 | −$35.5M | −$21.7M | — | — |
| Q4 2022 | 2022-12-31 | −$9.7M | — | — | — |
| Q3 2022 | 2022-09-30 | −$9.7M | — | — | — |
| Q2 2022 | 2022-06-30 | −$9.2M | — | — | — |
| Q1 2022 | 2022-03-31 | −$13.8M | — | — | — |
Disc Medicine free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$32.7M to −$181.3M, a net decrease of $148.6M. Disc Medicine's latest reported quarter, Q2 2026, generated −$44.2M in free cash flow, an increase of $3.8M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Disc Medicine filings at SEC.gov ↗